Works in Oncologist, 2021, Vol 26, Issue 4

Results: 39
    1
    2

    Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 288, doi. 10.1002/onco.13712
    By:
    • Kazandjian, Dickran;
    • Dew, Alexander;
    • Hill, Elizabeth;
    • Ramirez, Elizabeth Gil;
    • Morrison, Candis;
    • Mena, Esther;
    • Lindenberg, Liza;
    • Yuan, Constance;
    • Maric, Irina;
    • Wang, Hao‐Wei;
    • Calvo, Katherine;
    • Dulau‐Florea, Alina;
    • Roswarski, Joseph;
    • Emanuel, Michael;
    • Braylan, Raul;
    • Turkbey, Baris;
    • Choyke, Peter;
    • Camphausen, Kevin;
    • Stetler‐Stevenson, Maryalice;
    • Steinberg, Seth M.
    Publication type:
    Article
    3
    4
    5
    6
    7

    Caregiver–Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 310, doi. 10.1002/onco.13699
    By:
    • Loh, Kah Poh;
    • Mohamed, Mostafa R.;
    • Kadambi, Sindhuja;
    • Culakova, Eva;
    • Xu, Huiwen;
    • Magnuson, Allison;
    • Flannery, Marie;
    • Duberstein, Paul R.;
    • Epstein, Ronald M.;
    • McHugh, Colin;
    • Nipp, Ryan D.;
    • Trevino, Kelly M.;
    • Sanapala, Chandrika;
    • Hall, Bianca A.;
    • Canin, Beverly;
    • Gayle, Arlene A.;
    • Conlin, Alison;
    • Bearden, James;
    • Mohile, Supriya G.
    Publication type:
    Article
    8

    Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. e622, doi. 10.1002/onco.13632
    By:
    • Joseph, Cissimol P.;
    • Abaricia, Sarah N.;
    • Angelis, Michelle A.;
    • Polson, Kathleen;
    • Jones, Robin L.;
    • Kang, Yoon‐Koo;
    • Riedel, Richard F.;
    • Schöffski, Patrick;
    • Serrano, César;
    • Trent, Jonathan;
    • Tetzlaff, Eric D.;
    • Si, Tuan Dong;
    • Zhou, Teresa;
    • Doyle, Ashley;
    • Bauer, Sebastian;
    • Roche, Maria;
    • Havnaer, Tracy
    Publication type:
    Article
    9
    10
    11
    12

    Benefit–Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine‐ and Platinum‐Based Chemotherapy.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 318, doi. 10.1002/onco.13646
    By:
    • Pelosof, Lorraine;
    • Saung, May Tun;
    • Donoghue, Martha;
    • Casak, Sandra;
    • Mushti, Sirisha;
    • Cheng, Joyce;
    • Jiang, Xiling;
    • Liu, Jiang;
    • Zhao, Hong;
    • Khazraee, Maryam;
    • Goldberg, Kirsten B.;
    • Theoret, Marc;
    • Lemery, Steven;
    • Pazdur, Richard;
    • Fashoyin‐Aje, Lola
    Publication type:
    Article
    13
    14
    15

    FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
    By:
    • Pietrantonio, Filippo;
    • Fucà, Giovanni;
    • Rossini, Daniele;
    • Schmoll, Hans‐Joachim;
    • Bendell, Johanna C.;
    • Morano, Federica;
    • Antoniotti, Carlotta;
    • Corallo, Salvatore;
    • Borelli, Beatrice;
    • Raimondi, Alessandra;
    • Marmorino, Federica;
    • Niger, Monica;
    • Boccaccino, Alessandra;
    • Masi, Gianluca;
    • Lonardi, Sara;
    • Boni, Luca;
    • Braud, Filippo;
    • Di Bartolomeo, Maria;
    • Falcone, Alfredo;
    • Cremolini, Chiara
    Publication type:
    Article
    16
    17
    18

    Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. e639, doi. 10.1002/onco.13674
    By:
    • George, Suzanne;
    • Jones, Robin L.;
    • Bauer, Sebastian;
    • Kang, Yoon‐Koo;
    • Schöffski, Patrick;
    • Eskens, Ferry;
    • Mir, Olivier;
    • Cassier, Phillipe A.;
    • Serrano, Cesar;
    • Tap, William D.;
    • Trent, Jonathan;
    • Rutkowski, Piotr;
    • Patel, Shreyaskumar;
    • Chawla, Sant P.;
    • Meiri, Eval;
    • Gordon, Michael;
    • Zhou, Teresa;
    • Roche, Maria;
    • Heinrich, Micahel C.;
    • Mehren, Margaret
    Publication type:
    Article
    19
    20

    Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 341, doi. 10.1002/onco.13654
    By:
    • Zambelli, Alberto;
    • Chiudinelli, Lorenzo;
    • Fotia, Vittoria;
    • Negrini, Giorgia;
    • Bosetti, Tommaso;
    • Callegaro, Annapaola;
    • Di Croce, Andrea;
    • Caremoli, Elena Rota;
    • Moro, Cecilia;
    • Milesi, Laura;
    • Poletti, Paola;
    • Tasca, Cristina;
    • Mandalà, Mario;
    • Merelli, Barbara;
    • Mosconi, Stefania;
    • Arnoldi, Ermenegildo;
    • Bettini, Anna;
    • Bonomi, Lucia;
    • Messina, Caterina;
    • Ghilardi, Laura
    Publication type:
    Article
    21
    22

    Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. e588, doi. 10.1002/onco.13639
    By:
    • Takeda, Masayuki;
    • Takahama, Takayuki;
    • Sakai, Kazuko;
    • Shimizu, Shigeki;
    • Watanabe, Satomi;
    • Kawakami, Hisato;
    • Tanaka, Kaoru;
    • Sato, Chihiro;
    • Hayashi, Hidetoshi;
    • Nonagase, Yoshikane;
    • Yonesaka, Kimio;
    • Takegawa, Naoki;
    • Okuno, Tatsuya;
    • Yoshida, Takeshi;
    • Fumita, Soichi;
    • Suzuki, Shinichiro;
    • Haratani, Koji;
    • Saigoh, Kazumasa;
    • Ito, Akihiko;
    • Mitsudomi, Tetsuya
    Publication type:
    Article
    23
    24
    25
    26

    Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. e686, doi. 10.1002/onco.13640
    By:
    • Sagara, Yasuaki;
    • Mori, Masanori;
    • Yamamoto, Sena;
    • Eguchi, Keiko;
    • Iwatani, Tsuguo;
    • Naito, Yoichi;
    • Kogawa, Takahiro;
    • Tanaka, Kiyo;
    • Kotani, Haruru;
    • Yasojima, Hiroyuki;
    • Ozaki, Yukinori;
    • Noguchi, Emi;
    • Miyasita, Minoru;
    • Kondo, Naoto;
    • Niikura, Naoki;
    • Toi, Masakazu;
    • Shien, Tadahiko;
    • Iwata, Hiroji
    Publication type:
    Article
    27
    28
    29

    Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, Experience.

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. e597, doi. 10.1002/onco.13626
    By:
    • Jolivet, Catherine;
    • Nassabein, Rami;
    • Soulières, Denis;
    • Weng, Xiaoduan;
    • Amireault, Carl;
    • Ayoub, Jean‐Pierre;
    • Beauregard, Patrice;
    • Blais, Normand;
    • Carrier, Christian;
    • Cloutier, Alexis‐Simon;
    • Desnoyers, Alexandra;
    • Lemay, Anne‐Sophie;
    • Lemay, Frédéric;
    • Loungnarath, Rasmy;
    • Jolivet, Jacques;
    • Letendre, François;
    • Tehfé, Mustapha;
    • Vadnais, Charles;
    • Viens, Daniel;
    • Aubin, Francine
    Publication type:
    Article
    30

    Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%?

    Published in:
    Oncologist, 2021, v. 26, n. 4, p. 294, doi. 10.1002/onco.13633
    By:
    • Merola, Elettra;
    • Alonso Gordoa, Teresa;
    • Zhang, Panpan;
    • Al‐Toubah, Taymeyah;
    • Pellè, Eleonora;
    • Kolasińska‐Ćwikła, Agnieszka;
    • Zandee, Wouter;
    • Laskaratos, Faidon;
    • Mestier, Louis;
    • Lamarca, Angela;
    • Hernando, Jorge;
    • Cwikla, Jaroslaw;
    • Strosberg, Jonathan;
    • Herder, Wouter;
    • Caplin, Martin;
    • Cives, Mauro;
    • Leeuwaarde, Rachel
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39